62 related articles for article (PubMed ID: 34491768)
21. Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains.
Cilento ME; Reeve AB; Michailidis E; Ilina TV; Nagy E; Mitsuya H; Parniak MA; Tedbury PR; Sarafianos SG
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0116721. PubMed ID: 34516245
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic Radiosurgery for Treatment of Operculoinsular Refractory Epilepsy After Incomplete Resection in a Child.
Phan CD; Dang AT; Ton-Nu VA; Nguyen HS; Pham NH
Int Med Case Rep J; 2021; 14():597-603. PubMed ID: 34512041
[TBL] [Abstract][Full Text] [Related]
23. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention.
Tian Q; Quan P; Fang L; Xu H; Liu C
Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925
[TBL] [Abstract][Full Text] [Related]
24. Australian Meningococcal Surveillance Programme Annual Report, 2020.
Lahra MM; George CRR; Shoushtari M; Hogan TR
Commun Dis Intell (2018); 2021 Aug; 45():. PubMed ID: 34496732
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road.
Baheti N; Rathore C; Bansal AR; Shah S; Veedu HK; Prakash S; Kanhere K; Jaiswal SK; Jukkarwala A; Murthy JMK; Radhakrishnan K
Seizure; 2021 Nov; 92():112-117. PubMed ID: 34496330
[TBL] [Abstract][Full Text] [Related]
26. Adult gonococcal conjunctivitis: Prevalence, clinical features and complications.
Cuesta Chasco G; Carreras-Castañer X; Zboromyrska Y; Pitart C; Palma-Carvajal F; Bosch J; Figueroa-Vercellino JP
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34494952
[No Abstract] [Full Text] [Related]
27. Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland.
Gysin M; Acevedo CT; Haldimann K; Bodendoerfer E; Imkamp F; Bulut K; Buehler PK; Brugger SD; Becker K; Hobbie SN
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):64. PubMed ID: 34493302
[TBL] [Abstract][Full Text] [Related]
28. Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
Fong A; Ross M; Boudreau J; Nokhbeh R; Tilbe K; Lee H
PLoS One; 2021; 16(9):e0257143. PubMed ID: 34492076
[TBL] [Abstract][Full Text] [Related]
29. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
30. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents.
Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567
[TBL] [Abstract][Full Text] [Related]
31. How Cargo Identity Alters the Uptake of Cell-Penetrating Peptide (CPP)/Cargo Complexes: A Study on the Effect of Net Cargo Charge and Length.
Hymel HC; Rahnama A; Sanchez OM; Liu D; Gauthier TJ; Melvin AT
Cells; 2022 Apr; 11(7):. PubMed ID: 35406759
[TBL] [Abstract][Full Text] [Related]
32. Comparative Molecular Transporter Properties of Cyclic Peptides Containing Tryptophan and Arginine Residues Formed through Disulfide Cyclization.
Mohammed EHM; Mandal D; Mozaffari S; Abdel-Hamied Zahran M; Mostafa Osman A; Kumar Tiwari R; Parang K
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498339
[TBL] [Abstract][Full Text] [Related]
33. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
34. Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool.
Sajid MI; Moazzam M; Stueber R; Park SE; Cho Y; Malik NUA; Tiwari RK
Peptides; 2021 Jul; 141():170542. PubMed ID: 33794283
[TBL] [Abstract][Full Text] [Related]
35. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
[TBL] [Abstract][Full Text] [Related]
36. Amphiphilic Cell-Penetrating Peptides Containing Natural and Unnatural Amino Acids as Drug Delivery Agents.
Salehi D; Mozaffari S; Zoghebi K; Lohan S; Mandal D; Tiwari RK; Parang K
Cells; 2022 Mar; 11(7):. PubMed ID: 35406720
[TBL] [Abstract][Full Text] [Related]
37. Cyclic and Linear Peptides Containing Alternate WW and RR Residues as Molecular Cargo Delivery Tools.
Kim L; Lohan S; Moreno J; Zoghebi K; Tiwari RK; Parang K
Mol Pharm; 2023 Jan; 20(1):341-356. PubMed ID: 36445335
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
